Yan Chen
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD Study.Michael G Nanna, Carlos Mena-Hurtado, Victoria Divino
|Oct 15, 2025
Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes.Navdeep Tangri, Rakesh Singh, Yan Chen
|Sep 10, 2025
Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World).Kim G Smolderen, Carlos Mena-Hurtado, Zhenxiang Zhao
|Jun 17, 2025
Clinical Outcomes of Patients with SLE Treated with Belimumab, Without Versus With Prior Immunosuppressant Use: a US Claims Database Study.Karen H Costenbader, Maral DerSarkissian, Yan Chen
Pageof 1
Frequent Collaborators
2 joint publications
Michael G Nanna
1 joint publications
Karen H Costenbader
1 joint publications
Maral DerSarkissian
1 joint publications
Brendan Rabideau
1 joint publications
Karen Worley
1 joint publications
Theo Man
1 joint publications
Bernard Rubin
1 joint publications
S Sam Lim
1 joint publications
B Gabriel Smolarz
1 joint publications
Navdeep Tangri
